搜索临床试验以:ONC-392
总计6680个结果
-
University of California, San FranciscoCenters for Disease Control and Prevention; Kenya Medical Research Institute完全的
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
Jennifer KeiserNational Centre for Parasitology, Entomology and Malaria Control, Cambodia; National Institute...邀请报名
-
Geneticure, LLCUniversity of Minnesota; Fairview Health Services尚未招聘
-
Mark HatherillMedical Research Council; University of Oxford; Wellcome Trust; Department for International Development... 和其他合作者完全的
-
Red de Terapia CelularFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Hospital Universitario... 和其他合作者未知
-
Ono Pharma USA Inc终止
-
Seoul National University Hospital完全的
-
EDAP TMS S.A.Institut National de la Santé Et de la Recherche Médicale, France完全的
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)完全的
-
Ipsen完全的三阴性乳腺癌 | 实体瘤 | ER/PR 阳性乳腺癌 | 伴有活动性脑转移的转移性乳腺癌美国
-
Cascadian Therapeutics Inc.Celldex Therapeutics完全的